Logo image of MDLY

Medley Management Inc (MDLY) Stock Fundamental Analysis

NYSE:MDLY - New York Stock Exchange, Inc. -

5.88  +0.1 (+1.73%)

Fundamental Rating

1

MDLY gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. Both the profitability and financial health of MDLY have multiple concerns. MDLY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MDLY had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -7.49%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -14.15%
PM (TTM) -8.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

MDLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -3.68, we must say that MDLY is in the distress zone and has some risk of bankruptcy.
MDLY has a Debt/Equity ratio of -0.97. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.97
Debt/FCF N/A
Altman-Z -3.68
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

MDLY has a Current Ratio of 0.14. This is a bad value and indicates that MDLY is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLY has a Quick Ratio of 0.14. This is a bad value and indicates that MDLY is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14

More info and screens

0

3. Growth

3.1 Past

MDLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.00%, which is quite impressive.
MDLY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.92%.
The Revenue for MDLY have been decreasing by -13.18% on average. This is quite bad
EPS 1Y (TTM)29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
Revenue 1Y (TTM)-31.92%
Revenue growth 3Y-20.04%
Revenue growth 5Y-13.18%
Sales Q2Q%-20.43%

3.2 Future

Based on estimates for the next years, MDLY will show a decrease in Earnings Per Share. The EPS will decrease by -3.61% on average per year.
The Revenue is expected to decrease by -31.10% on average over the next years. This is quite bad
EPS Next Y0%
EPS Next 2Y-3.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.41%
Revenue Next 2Y-31.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDLY Yearly Revenue VS EstimatesMDLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
MDLY Yearly EPS VS EstimatesMDLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 2 4 6 8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDLY. In the last year negative earnings were reported.
Also next year MDLY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDLY Price Earnings VS Forward Price EarningsMDLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -57.79
MDLY Per share dataMDLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150

4.3 Compensation for Growth

MDLY's earnings are expected to decrease with -3.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.61%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.90%, MDLY is a good candidate for dividend investing.
In the last 3 months the price of MDLY has falen by -29.50%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average S&P500 Dividend Yield of 2.27, MDLY pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.9%

5.2 History

The dividend of MDLY decreases each year by -34.93%.
MDLY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-34.93%
Div Incr YearsN/A
Div Non Decr YearsN/A
MDLY Yearly Dividends per shareMDLY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2 4 6

5.3 Sustainability

MDLY's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-3.61%
EPS Next 3YN/A

More info and screens

Medley Management Inc

NYSE:MDLY (7/6/2021, 8:04:00 PM)

5.88

+0.1 (+1.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners403.16%
Ins Owner Change0%
Market Cap3.94M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 11.9%
Yearly Dividend0.7
Dividend Growth(5Y)-34.93%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -57.79
EPS(TTM)-4.26
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS49.63
BVpS-199.51
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.15%
PM (TTM) -8.01%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity -0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z -3.68
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
EPS Next Y0%
EPS Next 2Y-3.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.92%
Revenue growth 3Y-20.04%
Revenue growth 5Y-13.18%
Sales Q2Q%-20.43%
Revenue Next Year-11.41%
Revenue Next 2Y-31.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A